FDA, BIR to lower drug costs for seniors

THE Food and Drug Administration (FDA) is working closely with the Bureau of Internal Revenue (BIR) to make some essential medicines more affordable for senior citizens.

FDA Director General Samuel Zacate said the two agencies were now determining how to exempt certain medicines from the value-added tax (VAT) that would be consistent with the Corporate Recovery and Tax Incentives for Enterprises (Create) Act.

Register to unlock this article

Register to read this story and more for free.

Signing up for an account helps us improve your browsing experience.

Continue

OR

See our subscription options.

Already have an account? Log in here